Renamed Coave Therapeutics Raises $39m To Fund Its Next-Gen Gene Therapies
Conjugation Tech Could Improve Gene Delivery
Executive Summary
The company aims to overcome drawbacks of existing gene therapy platforms, starting in ocular and CNS diseases.